ASN Kidney Week 2025 – Comprehensive Updates in Nephrology On demand
$44.4
$72.37
Description ASN Kidney Week 2025 is the premier global nephrology conference organized by the American Society of Nephrology (ASN). This program delivers cutting-edge updates across the full spectrum of kidney disease, including clinical nephrology, dialysis, transplantation, genetics, artificial intelligence, and emerging therapies. Designed for nephrologists and the entire kidney care team, this course brings together world experts to share evidence-based insights and future-focused innovations shaping nephrology practice in 2025 and beyond. Course Overview ASN Kidney Week 2025 provides an in-depth educational experience covering advances in kidney disease research, diagnosis, and management. The program features expert-led lectures, case-based discussions, and technology-driven innovations to help clinicians improve patient outcomes and stay current with evolving standards of care. Course Objectives After completing this course, participants will be able to: Apply updated guidelines in the management of kidney diseases Integrate new technologies and AI tools into nephrology practice Improve decision-making for dialysis and transplant patients Understand genetic and precision-medicine approaches in nephrology Identify emerging therapies and research trends in kidney care Target Audience Nephrologists Internal Medicine Physicians Dialysis Physicians Transplant Specialists Fellows & Residents Advanced Practice Providers (NPs, PAs) Nurses and Allied Kidney Care Professionals files and runtime Course Name Duration A Lifespan Approach to Pediatric Hypertension – Guiding Care from Youth to Adulthood (ASN) 01:59:28 Addressing Symptoms in Dialysis-Dependent Kidney Disease (ASN) 01:32:27 Advancing Hypertension Care – Role of Renal Denervation (ASN) 01:59:24 AKI Advances – Biomarkers, Outcomes, and Clinical Trials (ASN) 01:30:06 AKI and Hepatorenal Syndrome – Diagnosis, Management, and Treatment (ASN) 01:10:15 AKI Everywhere All at Once – Risks, Trajectories, and Practice Patterns (ASN) 01:30:11 AKI Progression and Resolution – Cellular and Molecular Insights (ASN) 01:35:24 Aldosterone-Dependent and Independent Mechanisms in Sodium Transport and Hypertension (ASN) 02:06:03 An IOTA of Sense – Organ Transplant Access Model (ASN) 02:02:06 APOL1-Mediated Kidney Disease – Precision Nephrology (ASN) 02:08:12 Approach to Hypertension Treatment – Special Groups (ASN) 02:01:25 Artificial Intelligence and Data Science Transforming Kidney Care (ASN) 01:39:41 Banff Classification – Updates and Challenges (ASN) 02:06:16 Best in Show – Literature Review in Kidney Transplantation (ASN) 02:04:38 Best of ASN Journals 2025 – JASN, CJASN, Kidney360 (ASN) 02:01:21 Best of JAMA and NEJM (ASN) 02:04:37 Better Kidney Care Requires Better Payment Systems (ASN) 01:58:51 Beyond HLA – Genetics in Living Donor Transplantation (ASN) 02:03:11 Big Questions in Maintenance Dialysis (ASN) 01:49:28 Breaking Barriers – Complement-Mediated Kidney Diseases (ASN) 00:54:52 Bridging Gaps in CKD Care – Health Equity (ASN) 02:00:59 Bringing New Technologies to Dialysis Care (ASN) 01:58:04 Cardiovascular-Kidney-Metabolic Interactions (ASN) 02:00:09 Cardiovascular-Kidney-Metabolic Syndrome Case Discussions (ASN) 01:55:48 Case Studies in Glomerular Diseases 2025 (ASN) 02:03:05 Changing Landscape for Vasculitis Management (ASN) 02:00:16 Choosing the Optimal Dialysis Modality (ASN) 02:02:08 CKD in Limited-Resource Settings (ASN) 02:02:53 CKD in the US Hispanic-Latino Population (ASN) 01:31:59 CKD – Advancing Epidemiology and Prevention (ASN) 01:35:28 CKD – Mechanisms of Disease Progression (ASN) 01:43:22 CKD – Identifying Risks and Optimizing Outcomes (ASN) 01:23:15 Clinical Management of Cardiovascular-Kidney-Metabolic Diseases (ASN) 01:59:57 Clinical-Pathologic-Molecular Correlations in Diabetic Kidney Disease (ASN) 01:59:48 Considerations for Hemodiafiltration in Dialysis (ASN) 01:02:51 Controversies in Glomerular Disease Therapeutics (ASN) 02:07:21 Controversies in Kidney Dysfunction in Advanced Liver Disease (ASN) 01:55:51 Decoding AKI – The Omics Revolution (ASN) 01:52:51 Dialysis Vascular Access – Translational Science (ASN) 01:34:40 Dialysis-Dependent AKI – Therapies for Recovery (ASN) 01:55:23 Disaster and Humanitarian Emergencies in Nephrology (ASN) 02:01:01 Diversity and Equity in Kidney Health (ASN) 01:30:55 Don’t Let It Go to Your Head – Hyponatremia (ASN) 02:00:47 Effects of Diabetes Therapies on the Skeleton (ASN) 02:01:35 Emerging Insights on Kidney Stone Risk (ASN) 02:07:09 Emerging Mechanisms of AKI in CKM Syndrome (ASN) 01:38:11 Expanding Therapeutic Horizons in IgAN (ASN) 00:55:30 Exploring Diet, Exercise, and Microbiome in CKD (ASN) 01:28:38 Extending Glomerular Function in Aging (ASN) 02:00:16 Extracellular Vesicle-Based Therapeutics for CKD (ASN) 02:09:30 Fluid Therapy in Critical Care (ASN) 02:01:42 Fluids and Electrolytes – Bench and Bedside (ASN) 01:38:22 Genetic Insights into Tubular Function (ASN) 01:58:57 Genetic Testing in the Nephrology Clinic (ASN) 01:25:38 Genetics of Complex Kidney Traits (ASN) 01:33:34 Genetics, Big Data, and Multi-Omics (ASN) 01:35:47 Glomerular Disease Outcomes (ASN) 01:31:03 Glomerular Diseases and Women’s Health (ASN) 01:56:01 Glomerular Precision Nephrology (ASN) 01:32:32 Glomerular Targeted Therapies (ASN) 01:33:13 Guidance for Outpatient Dialysis for AKI (ASN) 02:00:59 SGLT2 Inhibitors in CKD (ASN) 02:04:13 Heart Failure Across the Spectrum of CKD (ASN) 01:57:38 Hemodialysis – Novel Interventions (ASN) 01:40:03 High-Impact Clinical Trials 1 (2025) (ASN) 01:43:21 High-Impact Clinical Trials 2 (2025) (ASN) 01:29:32 Histological Lessons from Modern Biopsy Cohorts (ASN) 01:52:43 Home Hemodialysis in Older Adults (ASN) 01:59:07 Hot Topics in Lupus Nephritis (ASN) 01:37:18 How to Combat AKI (ASN) 02:06:28 Precision CRRT Delivery (ASN) 02:04:25 Hyperkalemia – Zirconium & Patiromer Era (ASN) 02:00:55 Hypertension and Cardiorenal Disease (ASN) 01:26:20 HIF-PH Inhibitors in ESKD (ASN) 01:02:26 Immune-Mediated Kidney Diseases in Children (ASN) 01:24:14 Immunity and Hypertensive Kidney Damage (ASN) 01:55:48 Impacts of Nicotine, Cannabinoids, and Opioids (ASN) 02:02:42 Increasing Kidney Transplantation – State of the Art (ASN) 02:15:08 Incretin-Based Therapies in Nephrology (ASN) 01:59:16 Inflammation, ASCVD, and CKD (ASN) 01:00:05 Influence of Lower Urinary Tract on Pediatric Kidney Health (ASN) 01:57:31 Innovations in Pediatric Nephrology (ASN) 01:48:16 Integrative Omics for Precision CKD Treatment (ASN) 01:53:56 Iron and Mineral Metabolism (ASN) 02:09:58 Equity in Access to Home Dialysis (ASN) 02:04:46 Kidney Disease with Diabetes – Translational Science (ASN) 01:45:28 Kidney Tissue Genomics Revolution (ASN) 02:01:12 Kidney Transplant Modernization (ASN) 02:12:45 Late-Breaking Research Orals 1 (2025) (ASN) 01:19:30 Late-Breaking Research Orals 2 (2025) (ASN) 01:20:14 Late-Breaking Research Orals 3 (2025) (ASN) 01:19:09 Leading Edge of Therapeutic Development in Cystic Kidney Diseases (ASN) 01:51:54 Management of Challenging Dialysis Access (ASN) 02:00:48 RAAS Inhibitor Therapy After Hyperkalemia (ASN) 00:56:42 Mechanistic Insights on Urinary Stone Formation (ASN) 01:33:35 Membranous Nephropathy – Personalized Care (ASN) 01:39:30 Monogenic Kidney Disease (ASN) 01:38:47 Moving the Needle in Childhood Nephrotic Syndrome (ASN) 02:01:52 Navigating Human Leukocyte Antigens (ASN) 01:27:59 Nephrology Quiz and Questionnaire 2025 (ASN) 01:48:13 Nephrology Workforce – The Future Is Now (ASN) 02:03:48 New Developments in Bones, Stones, and Mineral Metabolism (ASN) 01:33:20 New Paradigms in Proteinuric Kidney Diseases (ASN) 02:00:14 Novel Immune Modulators of Allograft Rejection (ASN) 02:02:41 Novel Therapies for Phosphate & FGF23 Regulation (ASN) 01:55:25 Nutrition and CKD (ASN) 01:58:56 Onconephrology – Mainstream Advances (ASN) 02:14:17 Onconephrology – Updates and Mechanisms (ASN) 01:44:37 Opening Plenary – ASN President’s Address (2025) (ASN) 01:32:16 Optimizing B-Cell Targeted Therapies for Lupus Nephritis (ASN) 01:08:13 Pathology – Novel Mechanisms and Modalities (ASN) 01:39:04 Patient-Reported Outcomes in Kidney Care (ASN) 02:03:06 Pediatric Onconephrology (ASN) 01:59:27 Plenary – ASN Midcareer & Awards (2025) (ASN) 01:27:51 Plenary – ASN President’s Medal & Awards (2025) (ASN) 01:38:37 Plenary – In Memoriam & Xenotransplantation Panel (2025) (ASN) 00:40:42 Point-of-Care Ultrasonography in Nephrology (ASN) 02:02:19 Post-Transcriptional & Post-Translational Processing in Glomerular Disease (ASN) 01:58:39 Precision Medicine in Diabetic Kidney Disease (ASN) 01:30:52 Prenatal & Postnatal Effects on Kidneys (ASN) 02:04:17 Prevention of CKD-Associated Hyperphosphatemia (ASN) 00:56:44 Promoting Justice in Kidney Health (ASN) 02:11:31 Proteinuria & eGFR as Trial End Points in FSGS (ASN) 01:01:19 Proteinuria & Hypertension in Cancer Patients (ASN) 01:35:50 Peritoneal Dialysis for AKI (ASN) 01:31:24 Renal Biopsy – Clinical Correlations 2025 (ASN) 02:01:58 Renin-Angiotensin System & Kidney Function (ASN) 02:02:45 Resistant Hypertension – New Therapies (ASN) 02:01:40 Revisiting Mendelian Kidney Diseases (ASN) 02:04:04 Complement in ANCA-Associated Vasculitis (ASN) 00:51:50 Immune System in CKD (ASN) 01:58:50 Advanced Tissue Imaging Technologies (ASN) 01:53:41 Sepsis-Associated AKI (ASN) 01:24:00 Sex & Kidney Metabolism (ASN) 01:59:54 Small Molecules in CKD-MBD (ASN) 01:37:54 Success Stories in Glomerular Diseases (ASN) 02:04:39 Team Science & Multi-Omics in Diabetic Kidney Disease (ASN) 02:04:51 Far Side of the Nephron (ASN) 02:00:26 Therapeutic Landscape in Diabetic Kidney Disease (ASN) 01:59:24 Therapeutics in AKI (ASN) 02:07:09 Translating Evidence in AKI & Critical Care Nephrology (ASN) 01:56:58 Transplantation – Basic Science Innovations (ASN) 01:28:53 Transplantation – Clinical Controversies (ASN) 01:28:26 US Policy Changes Impacting Kidney Care (ASN) 01:54:56 Unraveling the Mysteries of AKI (ASN) 02:02:35 Pediatric Kidney Disease Clinical Trials (ASN) 02:00:48 What’s New at Home Dialysis (ASN) 01:29:42 Young People, Grown-Up Kidney Diseases (ASN) 01:54:58
Nephrology